Cargando…
The Burden of Hypercoagulability in COVID-19
The novel coronavirus disease 2019 (COVID-19) infection has widespread impact on multiple organ systems, including damage to endothelial cells. Various studies have found evidence for direct mechanisms by which interaction between severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and endo...
Autores principales: | Kim, Madeleine, George, Andrew, Ganti, Latha, Huang, Derrick, Carman, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054923/ https://www.ncbi.nlm.nih.gov/pubmed/35707624 http://dx.doi.org/10.1055/a-1760-0445 |
Ejemplares similares
-
Hypercoagulable State in COVID-19: A Case Series of Three Patients
por: Logan, Gideon, et al.
Publicado: (2020) -
Rare Presentation of Deep Vein Thrombosis and Submassive Pulmonary Emboli Due to Hypercoagulable State With Supratherapeutic Anticoagulation
por: Rivera-Morales, Mark D, et al.
Publicado: (2021) -
Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020) -
Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023) -
A Less Virulent COVID-19 Pneumonia
por: George, Andrew, et al.
Publicado: (2020)